2nd European Workshop on Healthy Living with HIV – Presentations

 

Friday 15 September 2017

  Session 1: What still needs to be improved in our future HIV drugs?
 
HIV Macroprevention; epidemiology, phylogenic and networks
Dr. C. Boucher, Erasmus Medical Center, The Netherlands
 
The impact of antiretroviral drugs on renal function
Dr. B. Hendry, King’s College London, London
 
The impact of antiretroviral drugs on cardiovascular health
Dr. J. Lopez-Sendon, La Paz Hospital, Spain
 
Optimizing antiretroviral drugs for the Aging patient (coming soon)
Dr. G. Guaraldi, University of Modena and Reggio Emilia, Italy
 
Case discussion: Co-morbidities in people living with HIV
Dr. R. Parades, IrsiCaixa Foundation, Spain
  Abstract presentations
 Risk of progression to osteoporosis in HIV-infected subjects and role of protease inhibitors
Dr. N. Perez - Alvares, Fight Against Aids Foundation, Spain
 15 years Follow Up in a Cohort of Children diagnosed with HIV Cardiomyopathy
Dr. A.M. Tudor, University Of Medicine And Pharmacy “Carol Davila” Bucharest, Romania
  Session 2: How best to monitor our HIV treated patients over the coming decade?
 
The future of patient monitoring  (coming soon)
Dr. H.J.Stellbrink, University of Hamburg, Germany
 
Case discussion: How do drugs/patients impact need and type of monitoring
Dr. L. Waters, University College London Hospitals, United Kingdom
 
Case discussion: How do drugs/patients impact need and type of monitoring
Dr. M. Boffito, Chelsea and Westminster Hospital, United Kingdom
  Abstract presentations
 Underdiagnosis and suboptimal care of diabetes mellitus in a French HIV-infected cohort in 2016.
Dr. A. Sautereau, Aphp, France
 The rate of HIV transmission within serodiscordant heterosexual couples
Dr. A. Tudor, University Of Medicine And Pharmacy “Carol Davila” Bucharest, Romania
  Session 3: How can social media be optimally utilized to improve patient care?
 
The role of social media in optimizing medical care
Dr. M. Hodson, National AIDS Manual, United Kingdom
 
Case discussion: Demonstrative cases of social media based HIV and medical non-HIV programs in the community
Dr. G. van den Berk, Onze Lieve Vrouwe Gasthuis, The Netherlands
  Abstract presentations
 Comprehensive and multidisciplinary assessment of HIV-infected population aged 60 years or older. Over60 cohort.
Dr. E. Negredo, Hospital Germans Trias I Pujol, Spain
 Developing a ChemSex Care Plan
Dr. D. Stuart, Chelsea and Westminster Hospital, United Kingdom

 

Saturday 16 September 2017

  Session 4: Cost and Effectiveness – Where Do They Meet?
 
Value-based healthcare in HIV management – The Economists Perspective
Dr. P. McEwan, Centre for Health Economics, Swansea University, United Kingdom
 
Value-based healthcare in HIV management – The Clinicians’ Perspective
Dr. J.J. Parienti, Hopital Caen, France
 
Value-based healthcare in HIV management – The Patienst’ Perspective - real life (coming soon)
Dr. K. Brinkman, Onze Lieve Vrouwe Gasthuis, The Netherlands